You are on page 1of 42

Key Points from

VAs & SCD


Guidelines
Asst. Prof. Sarawuth Limprasert, MD
Phramongkutklao Hospital

SLIDESMANIA.COM
SLIDESMANIA.COM
SLIDESMANIA.COM
Public BLS and access to AEDs

● Survival rates of OHCA victims continue to remain alarmingly low


with an overall survival rate of <15%
● Bystander CPR + public access defibrillators → better outcome and
survival of OHCA patients

SLIDESMANIA.COM
Yan S, et al. Critical care 2020;24:61.
Hallstrom AP, et al. N Engl J Med 2004;351:637–46.
Kragholm K, et al. N Engl J Med 2017;376:1737–47.
Nakashima T, et al. Lancet 2019;394:2255–62.
Pollack RA, et al. Circulation 2018;137:2104–13.
Public BLS and access to AEDs
Public access AEDs

Bystanders CPR

Community BLS training

Mobile phone-based
alerting of BLS-trained
volunteers

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
SLIDESMANIA.COM
Definition of electrical storm

● ≥3 episodes of sustained VA occurring within 24 h


● Require either ATP or cardioversion/defibrillation
● Each event separated by at least 5 min

Consequence

● Psychological disorder
● HF decompression
● Increase mortality

SLIDESMANIA.COM
SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
Deep sedation/intubation
Catheter ablation

SLIDESMANIA.COM
Overdrive pacing
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
SLIDESMANIA.COM
Genetic counselling and testing
● Genetic testing becomes routine part of the care in patients with
genetic cardiomyopathies and arrhythmia syndromes → impact for
both prognosis and treatment
● Generally, genetic testing is recommended when a condition with a
likely genetic basis and a risk of VA and SCD is diagnosed in a living
or deceased patient
○ DCM/HNDCM + Other risk factors or a FH of DCM
○ Sporadic cases under suspicious circumstances for an inherited
etiology e.g. ARVC, HCM, LQTS, Andersen-Tawil syndrome, BrS,
CPVT, and SQTS
○ Focused genetic testing in ERS and idiopathic VF

SLIDESMANIA.COM
Living or deceased individual

Pathogenic / Likely pathogenic →


Genetic testing in first-degree and symptomatic relatives

SLIDESMANIA.COM
SLIDESMANIA.COM
Increasing relevance of CMRI
● CMR not only for diagnostic evaluation of patients with newly
documented VA
○ when SHD not related to coronary artery disease is suspected
○ frequent PVCs
○ VT that are not typical for an idiopathic origin
● CMR in all survivors of SCA without a clear underlying cause &
relatives of decedents of SADS
● Notably, LGE on CMR is not (yet) recommended as an additional risk
marker in the HCM risk calculator, despite its association with an
increased risk of VAs

SLIDESMANIA.COM
SLIDESMANIA.COM
Algorithms for AAD therapy
● AAD remain integral part of the m agement of VA as adjunctive
therapy, especially for symptomatic patients with frequent VA
● The recent guideline for the first time includes algorithms for
evaluation and follow-up of patients requiring sodium channel
blocking agents and QT-prolonging drugs
● At the same time AAD carry the risk of adverse events, e.g.
proarrhythmia

SLIDESMANIA.COM
Algorithms for
AAD therapy
a
http://www.brugadadrugs.org

c
Co-administration of drugs with AV nodal
blocking effect in patients with AF or AFL

d
In ICD carriers, a higher risk of drug-induced
pro-arrhythmia might be accepted

f
A ΔQRS >25% is not an absolute cut-off value
but dependent on QRS width before drug
initiation and individualized patient risk–benefit
considerations

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
Algorithms for
AAD therapy

a
http://www.crediblemeds.org

b
If strong indication and no alternative
treatment, consult a specialist

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
SLIDESMANIA.COM
Increasing value of catheter ablation in the
management of VA

SLIDESMANIA.COM
Hilke Könemann, et al. Europace. 2023 May 19;25(5):euad091.
Increasing value of catheter ablation in the
management of VA

SLIDESMANIA.COM
Hilke Könemann, et al. Europace. 2023 May 19;25(5):euad091.
Increasing value of catheter ablation in the
management of VA

SLIDESMANIA.COM
Hilke Könemann, et al. Europace. 2023 May 19;25(5):euad091.
Increasing value of catheter ablation in the
management of VA

SLIDESMANIA.COM
Hilke Könemann, et al. Europace. 2023 May 19;25(5):euad091.
Increasing value of catheter ablation in the
management of VA

SLIDESMANIA.COM
Hilke Könemann, et al. Europace. 2023 May 19;25(5):euad091.
Increasing value of catheter ablation in the
management of VA

SLIDESMANIA.COM
Hilke Könemann, et al. Europace. 2023 May 19;25(5):euad091.
SLIDESMANIA.COM
Algorithms for AAD therapy
● Generally, these new recommendations blaze a trail from a strong
focus on left ventricular function to ‘new’ risk markers which are also
taken into consideration for refining the SCD risk in patients with
intermediate risk

SLIDESMANIA.COM
SLIDESMANIA.COM

Pathogenic mutations in LMNA, PLN, FLNC, and RBM20 genes

Hilke Könemann, et al. Europace. 2023 May 19;25(5):euad091.


Programmed
Electrical
Stimulation
(PES)

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
Programmed Electrical Stimulation (PES)

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
SLIDESMANIA.COM
HCM Risk-Kids model for SCD in childhood
HCM

https://hcmriskkids.org/

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
https://lmna-risk-vta.fr/

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
https://1-2-3-lqt.unipv.it/

SLIDESMANIA.COM
2022 ESC Guidelines for the management of patients with VAs and the prevention of SCD
CONCLUSION

SLIDESMANIA.COM
Conclusion - Key Points
● BLS training → Bystanders CPR + AEDs
● Electrical storm
○ Definition
○ Cause?
■ Inappropriate/Unnecessary ICD therapy → ICD programming
○ Therapy
■ Treat cause & consider catheter ablation
■ Medication
■ Overdrive pacing
■ Deep sedation/intubation
■ MCS

SLIDESMANIA.COM
■ Autonomic modulation
Conclusion - Key Points
● Genetic counselling and testing
○ Living or deceased individual
○ Pathogenic / Likely pathogenic → Genetic testing in first-degree
and symptomatic relatives
● Sodium channel blocker agents / drug associated with QT
prolongation
○ Contraindication/Precaution
○ Consider to change/reduce dose
■ Sodium channel blocker: △QRS >25% or
abnormal exercise test → new BBB, △QRS >25%, or QRS >130 ms
■ Drug associated QT prolongation: QT >500 ms

SLIDESMANIA.COM
Conclusion - Key Points
● Catheter ablation
○ Sustained VAs triggered by a PVC
○ CAD
■ Recurrent SMVT or ICD shocks despite medication
(amiodarone, beta-blocker, sotalol)
■ Hemodynamically well-tolerated SMVT + LVEF ≥40% (as an
alternative to ICD)
■ Before or immediately after ICD implantation
○ DCM/HNDC: BBRVT
○ Post TAVI: BBRVT
○ BrS: recurrent appropriate ICD shocks

SLIDESMANIA.COM
○ Idiopathic PVCs/VT: asymptomatic + PVC burden >20%
Conclusion - Key Points
● PES
○ CAD + LVEF 36-40% + NSVT or unexplained syncope
○ DCM/HNDCM: one of risk factors
○ ARVC + moderate RV or LV dysfunction
○ Asymptomatic spontaneous type I Brugada ECG

SLIDESMANIA.COM
THANK YOU
Q&A?
sarawuthlim@pmk.ac.th

SLIDESMANIA.COM

You might also like